(1 year, 9 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Order. The hon. Gentleman might want to keep within the confines of the motion that we are debating. This is about the economic impact of covid-19 lockdowns.
Absolutely, and the place I worked at, AstraZeneca, is a huge contributor to the British economy, not just through its manufacture of drugs, but through its research and development effort. The pharmaceutical sector is a vital part of the British economy. This goes broader than the big pharmaceutical companies, however. Smaller organisations, especially medical research charities, are an important part of the British life science sector. What did the disruption to their research effort mean? There are many rare medical conditions that need treatment. That research contributes to the economy, and the landscape in which the sector operates is a significant factor in our economy. If a lockdown disrupts medical research at an early stage, when the charity is raising money for research—perhaps recruiting a researcher and getting people on to clinical trials—it takes a long time for that medical research charity to regain those funds. Perhaps funds were raised through sporting events and other activities; that money has to be got back. They then have to recruit a researcher, or even a team of researchers, to look into getting the clinical trial started. There are many other aspects to it, too. The process takes a very long time.
The life expectancy lost due to the economic disruption has been mentioned. We should also think of the pharmaceutical and other products that would have been produced in that time. People’s life chances have been hindered because the medical progress that we would have made during that period was not achieved. If we look at all the different parts of our society, including the high streets and medical research, the disruption has been profound. This is partly about jobs when people leave school, but also about jobs in businesses and industries. We should also consider the life opportunities for people receiving medical treatment, and their ability to maintain their position in the workplace, which might be taken away if they do not get medical support.
At the beginning of covid and the lockdown, people did not realise or appreciate their impact. I think of what happened as a pulling on the thread of society, and the breaking of the bonds that bind us. Knitting them back together is challenging and difficult. It is expensive and takes a long time. In the meantime, the problems are difficult. I hope that my hon. Friend the Minister will reflect on that. In future such situations, whether the issue is covid or something else that has come along, I hope the Government will do a cost-benefit analysis, and will ask: if we need restrictions, what will that mean for all sectors of society?
The hon. Lady is making a powerful argument. One of the points that has been raised, which is part of the broader debate, is that we saw what was happening in China and Italy. People in Britain were already voluntarily choosing to restrict their activities and restrict going into work—
Order. I gently remind both speakers that we are talking about the economic impact of covid lockdowns. I also remind the hon. Lady that the shadow Minister and Minister have yet to speak, and I would like to allow at least a couple of minutes for the right hon. Member for Tatton (Esther McVey) to sum up. Please bear that in mind.